3National Committee for Clinical Labortory Standards, Performance standards for antimicrobialbility testing: ninth susceptlonformational supplement NCCLSdocument M100- S9. Wayne permsywania:NCCLS, 1999; 19:20--36.
4C. pena, M. pujol. Risk factors for faecal carriage of Klebsiella pneumomae producing extended- spectrum β- lactamase(ESBL- KP)in the intensive care unit. Journal of hosgital infection, 1997; 35 : 9 - 16.
5National Committee for Clinical Labortory Standards for antimicrobial susceptibility testing. Ninth Informational standards [M]. Performance Standards M100-S9. Pennsylvania:NCCLS, 1999. 1-103.
6Bush K, Jacoby GA, Medeiros AA. A function classification scheme for beta-lactamases and its correlation with molecular structure [J]. Antimicrob Agents Chemother, 1995, 39 (6) :1211-1233.
7Livemore DM, Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp.from intensive care units in Europe [ J ]. J Antimicrob Chemother, 1996, 38(3) : 409-424.
8Parerson DL, Yu VL. Extended-spectrum beta-lactamases:a call for improved detection and control[J]. Clin Infect Dis,1999, Z9(6): 1419-1422.
